Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease activity following pregnancy-related discontinuation of natalizumab in MS.
Kleerekooper I, van Kempen ZLE, Leurs CE, Dekker I, Rispens T, Lissenberg-Witte BI, van Munster CEP, de Jong BA, van Oosten BW, Uitdehaag BMJ, Wattjes MP, Killestein J. Kleerekooper I, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Dec 5;5(1):e424. doi: 10.1212/NXI.0000000000000424. eCollection 2018 Jan. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 29379823 Free PMC article.
Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod.
de Jong BA, van Kempen ZLE, Wattjes MP, Smit PM, Peferoen L, Berry D, Chamuleau MED, de Jong D. de Jong BA, et al. Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e483. doi: 10.1212/NXI.0000000000000483. eCollection 2018 Sep. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30027107 Free PMC article. No abstract available.
71 results